Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

OneMedNet (ONMD) EBIAT (2022 - 2025)

OneMedNet has reported EBIAT over the past 4 years, most recently at -$3.1 million for Q4 2025.

  • Quarterly EBIAT fell 32.28% to -$3.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.8 million through Dec 2025, up 72.36% year-over-year, with the annual reading at -$2.8 million for FY2025, 72.36% up from the prior year.
  • EBIAT was -$3.1 million for Q4 2025 at OneMedNet, down from -$741000.0 in the prior quarter.
  • Over five years, EBIAT peaked at $3.0 million in Q2 2025 and troughed at -$33.4 million in Q4 2022.
  • The 4-year median for EBIAT is -$2.2 million (2024), against an average of -$4.8 million.
  • Year-over-year, EBIAT tumbled 8929.52% in 2023 and then surged 183.09% in 2025.
  • A 4-year view of EBIAT shows it stood at -$33.4 million in 2022, then skyrocketed by 92.54% to -$2.5 million in 2023, then rose by 4.93% to -$2.4 million in 2024, then crashed by 32.28% to -$3.1 million in 2025.
  • Per Business Quant, the three most recent readings for ONMD's EBIAT are -$3.1 million (Q4 2025), -$741000.0 (Q3 2025), and $3.0 million (Q2 2025).